Concepedia

Shu-Fang Chang

SC

Statistics

Publications

8

Citations

238

H-Index

8

Active since

2014

Affiliations

Taipei Tzu Chi Hospital(Current)

Tzu Chi University

Mackay Memorial Hospital

Tzu Chi Foundation

China Medical University

Shu-Fang Chang is an author at Taipei Tzu Chi Hospital specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

2014–2023

8

Publications

8

Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling

Sung-Ying Huang, Shu-Fang Chang, Kuan‐Fu Liao et al. · International Journal of Molecular Sciences · 2017 · 50 citations · Full text

, , +16

The Protective Effect of Hispidin against Hydrogen Peroxide-Induced Oxidative Stress in ARPE-19 Cells via Nrf2 Signaling Pathway

Sung-Ying Huang, Shu-Fang Chang, Siu-Fung Chau et al. · Biomolecules · 2019 · 44 citations · Full text

, , +17

Potential Therapeutic Roles of Tanshinone IIA in Human Bladder Cancer Cells

Sheng‐Chun Chiu, Sung-Ying Huang, Shu-Fang Chang et al. · International Journal of Molecular Sciences · 2014 · 30 citations · Full text

, , +14

Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells

Sheng‐Chun Chiu, Tsung‐Lang Chiu, Sung-Ying Huang et al. · BMC Complementary and Alternative Medicine · 2017 · 30 citations · Full text

, , +15

The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma

Cheng‐Chan Yu, Sung-Ying Huang, Shu-Fang Chang et al. · Molecules · 2020 · 25 citations · Full text

, , +17

1–5 of 8